Market Vectors Biotech ETF (BBH)

  • Loading...
#9

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 16 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Good
Tracking Error Good
Bid/Ask Ratio Typical
Holdings Diversity Good

Fund Description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Fund Snapshot Updated 04.16.2014

Previous Close $85.55 Expense Ratio 0.35%
YTD Return 3.28% Avg. 30-Day Volume 315,057
1-Year Return 25.7% Market Cap Loading...
Bid $85.58 Shares Outstanding 5,896,000
Ask $85.62 Dividends $0.00
Top 10 Holdings
Gilead Sciences Inc (GILD) 12.48%
Amgen Inc (AMGN) 11.42%
Biogen Idec Inc (BIIB) 9.02%
Celgene Corp (CELG) 8.83%
Regeneron Pharmaceuticals (REGN) 5.20%
Alkermes Plc (ALKS) 5.10%
Alexion Pharmaceuticals Inc (ALXN) 4.94%
Illumina Inc (ILMN) 4.28%
Vertex Pharmaceuticals Inc (VRTX) 4.28%
Biomarin Pharmaceutical Inc (BMRN) 3.92%
% of Total Holdings 69.50%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds